4.7 Article

Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 44, Issue 1, Pages 143-149

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.44.1.143-149.2000

Keywords

-

Funding

  1. NIAID NIH HHS [R01 AI39115, R01 AI039115, R37 AI039115, R01 AI41937, R01 AI042159, R01 AI42159, P01 AI044975] Funding Source: Medline
  2. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039115, R01AI041937, R01AI042159, P01AI044975, R37AI039115] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Cyclosporine (CsA) is an immunosuppressive and antimicrobial drug which, in complex with cyclophilin A, inhibits the protein phosphatase calcineurin. We recently found that Cryptococcus neoformans growth is resistant to CsA at 24 degrees C but sensitive at 37 degrees C and that calcineurin is required for growth at 37 degrees C and pathogenicity. Here CsA analogs were screened far toxicity against C. neoformans in vitro. In most cases, antifungal activity was correlated,vith cyclophilin A binding in vitro and inhibition of the mixed-lymphocyte reaction and interleukin 2 production in cell culture. Two unusual nonimmunosuppressive CsA derivatives, (gamma-OH) MeLeu(4)-Cs (211-810) and D-Sar (alpha-SMe)(3) Val(2)-DH-Cs (209-825), which are also toxic to C. neoformans were identified. These CsA analogs inhibit C. neoformans via fungal cyclophilin A and calcineurin homologs. Our findings identify calcineurin as a novel antifungal drug target and suggest nonimmunosuppressive CsA analogs warrant investigation as antifungal agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available